Table 1.
Baseline clinical characteristics
| Variable | Men, n = 162 | Women, n = 49 | P Value |
|---|---|---|---|
| Age, y | 55.7 ± 11.2 | 60.2 ± 8.2 | 0.01 |
| Risk factors | |||
| HTN | 70 (43.2) | 25 (51.0) | 0.41 |
| Hyperlipidemia | 65 (40.1) | 22 (44.9) | 0.62 |
| DM | 32 (19.8) | 13 (26.5) | 0.32 |
| Current smoker | 87 (62.6) | 11 (26.2) | 0.02 |
| D2B time, min | 15 (25–35) | 17.5 (30–38) | 0.92 |
| Delay from symptom onset to reperfusion, h | 5.5 ± 4.4 | 7.6 ± 6.1 | 0.01 |
| Medications before admission | |||
| ASA | 61 (37.7) | 17 (35.4) | 0.74 |
| Statins | 8 (4.9) | 4 (8.2) | 0.48 |
| Laboratory parameters | |||
| TC, mg/dL | 139.1 ± 78.5 | 161.6 ± 74.9 | 0.08 |
| LDL‐C, mg/dL | 91.8 ± 56.6 | 106.0 ± 53.0 | 0.12 |
| HDL‐C, mg/dL | 36.8 ± 21.5 | 43.9 ± 21.4 | 0.05 |
| TG, mg/dL | 117.5 ± 97.0 | 127.2 ± 86.8 | 0.53 |
| HbA1c, % | 6.5 ± 1.4 | 6.7 ± 1.6 | 0.55 |
| eGFR, mL/min | 99.9 ± 28.8 | 99.3 ± 29.0 | 0.89 |
| hs‐CRP, mg/L | 6.03 ± 5.42 | 7.27 ± 5.52 | 0.16 |
| Peak TnI, μg/L | 32.6 (76.0–144.8) | 22.5 (72.4–135.3) | 0.67 |
Abbreviations: ASA, acetylsalicylic acid (aspirin); D2B, door‐to‐balloon; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin; HDL‐C, high‐density lipoprotein cholesterol; hs‐CRP, high‐sensitivity C‐reactive protein; HTN, hypertension; IQR, interquartile range; LDL‐C, low‐density lipoprotein cholesterol; SD, standard deviation; TC, total cholesterol; TG, triglycerides; TnI, troponin I.
Data are presented as n (%), mean ± SD, or median (IQR).